Feist-Weiller Cancer Center Logo  
Home | Maps & Directions | About Us | Contact | How to Help
Search:    Submit Search
September 16, 2014 - 8:20pm | 86°F
Patient Care | Clinical Studies | Scientific Research | Education | For Professionals | Support & Resources | Treatment at FWCC | Cancer Survivorship
Patient Care
Clinical Studies
Scientific Research
For Professionals
FWCC Giving Opportunities
eNewsletter Signup

FWCC Among the Three Sites Awarded $5.6M Clinical Trials Network Grant

clientuploads/_photos/Kelli/Dr Mills.pngPatients with cancer–particularly the underserved–will have local access to National Cancer Institute clinical trials through a new regional network that will serve Louisiana and parts of Mississippi. The Gulf South Minority/Underserved NCI Community Oncology Research Program (NCORP) is being established with a $5.6 million grant from the National Cancer Institute. This comprehensive cancer management program creates a network of physicians, nurses and researchers from major teaching and private medical institutions in Louisiana and Mississippi to deliver the latest promising investigational treatments for cancer.  While open to all cancer patients, the focus is minority and underserved patients who die at higher rates from cancer than others.

For more information, click here

FWCC Partners with Caris to Establish Tumor Profiling Program

Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient’s cancer tumor.  Once that information is known, physicians can identify tailored chemotherapy or radiation regimens to attack it. The new capability is the result of emerging technology called tumor profiling. Feist-Weiller will partner with Caris Life Sciences to offer the breakthrough technology to cancer patients of University Health Shreveport, a clinical partner of the LSU Health Shreveport School of Medicine. 

The region’s first clinical molecular profiling program will use Caris’ industry leading comprehensive tumor profiling service, Caris Molecular Intelligence TM, to enhance the clinical and research expertise of Feist-Weiller Cancer Center. It will expand the center’s personalized medicine approach to care and offer more precise treatment planning for patients. The partnership with Caris also includes clinical support, patient and physician education and system integration.  It also creates a forum to pursue joint research opportunities.

Learn more about Tumor Profiling by clicking here 



Feist-Weiller Cancer Center 1501 Kings Highway Shreveport, LA 71103
Privacy Policy
LSU Health Shreveport is an equal opportunity affirmative action institution.
2009-2015 LSU Health Shreveport
Search | Feist-Weiller Home | Contact | Sitemap
| LSU Health Shreveport Home | Email | Webmaster